Neurogenic bladder diagnosis, management, and follow-up: An update from the 2016 SIU-ICUD Meeting.

Adam Klein, Teresa L Danforth


Neurogenic bladder (NGB) is a congenital or acquired condition in which bladder function and behavior changes as a result of neurologic dysfunction.  Presentation, symptoms and natural history are variable, often resulting in a wide range of management and follow-up protocols.  There are no formal guidelines established for management and follow-up of NGB patients to date.  The Societe Internationale d’Urologie-International Consultation on Urologic Diseases (SIU-ICUD) has recently met to establish guidelines for these patients with a particular focus on follow-up and management of urologic complications.  The purpose of this paper is to review pathophysiology, diagnosis, treatment and surveillance in this particularly challenging subset of patients.


neurogenic bladder; urodynamics

Full Text:

 Subscribers Only


Yoshimura N, Chancellor MB. Physiology and pharmacology of the bladder and urethra. In: Wein AJ, Kavoussi LR, Novick AC, et, al, editors. Campbell-Walsh urology, vol. 3, 10th edition. Philadelphia: Elsevier; 2012. p. 1786-1833.

Wein AJ. Pathophysiology and classification of lower urinary tract dysfunction: overview. 1834-1846. In: Wein AJ, Kavoussi LR, Novick AC, et, al, editors. Campbell-Walsh urology, vol. 3, 10th edition. Philadelphia: Elsevier; 2012. pp. 1786-1833.

Weld KJ, Dmochowski RR. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology 2000;55(4):490-4.

Blaivas JG, Kaplan SA. Urologic dysfunction in patients with multiple sclerosis. Semin Neurol 1988;8(2):159-65.

Wyndaele JJ, Castro D, Madersbacher H. Neurogenic and faecal incontinence. In: Abrams P, editor. Incontinence. Paris: Health Publications; 2005. pp. 1059-1162.

Wein, AJ, Dmochowski RR. Neuromuscular dysfunction of the lower urinary tract. In: Wein AJ, Kavoussi LR, Novick AC, et, al, editors. Campbell-Walsh urology, vol. 3, 10th edition. Philadelphia: Elsevier; 2012. p. 1909-1946.

Burakgazi AZ, Alsowaity B, Burakgazi ZA, Unal D, Kelly JJ. Bladder dysfunction in peripheral neuropathies. Muscle Nerve 2012;45(1):2-8.

Danforth TL, Ginsberg DA. Neurogenic ower urinary tract dysfunction: how, when, and with which patients do we use urodynamics? Urol Clin North Am 2014;41(3):445-52.

Leu PB, Diokno AC. Epidemiology of the neurogenic bladder. In: Corcos J, Schick E, editors. (United Kingdom): Informa Healthcare; 2008.

Barrett DM. Disposable (infant) surface electrocardiogram electrodes in urodynamics: a simultaneous comparative study of electrodes. J Urol 1980;124(5):663-5.

McGuire EJ. Urodynamics of the neurogenic bladder. Urol Clin North Am 2010;37(4):507-16.

Light K, Cinman A, Giles GR, et al. Urodynamics in congenital neurogenic bladder. S Afr J Surg 1978;16(4):237-40.

McGuire EJ, Woodside JR, Borden TA, et al. Prognostic value of urodynamic testing in myelodysplastic patients. 1981. J Urol 2002;167(2 Pt. 2):1049-53 [discussion: 1054].

Ghoneim GM, Bloom DA, McGuire EJ, et al. Bladder compliance in meningomyelocele children. J Urol 1989;141(6):1404-6.

Harrison SC, Lawrence WT, Morley R, Pearce I, Taylor J. British Association of Urological Surgeons’ suprapubic catheter practice guidelines. BJU Int 2011;107(1):77-85.

Di Benedetto P. Clean intermittent catheterization in neuro-urology. Eur J Phys Rehabil Med 2011;47(4):651-9.

Woodward S, Steggal M, Tinhunu J. Clean intermittent catheterization: improving quality of life. Br J Nurs 2013;22(9):S20, S22-5.

Dorsher PT, McIntosh PM. Neurogenic bladder. Adv Urol 2012;2012:816274.

Padmanabhan P, Scarpero HM, Milam DF, Dmochkowski RR, Penson DF. Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity. World J of Urol 2011;29(1):51-7.

Hohenfellner M, Humke J, Hampel C, et al. Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction: long-term results with unilateral implants. Urology 2001;58(6):887-92.

Gurocak S, Nuininga J, Ure I, et al. Bladder augmentation: Review of the literature and recent advances. Indian J Urol 2007;23(4):452-7.

Herschorn S, Hewitt RJ. Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology 1998;52(4):672-8.

Reynard JM, Vass J, et al. Sphincterotomy and the treatment of detrusor-sphincter dyssynergia: current status, future prospects. Spinal Cord 2003;41(1):1-11.

Stoffel JT, Barrett DM. The artificial genitourinary sphincter. BJU Int 2008;102(5):644-58.

Daneshmand S, Ginsberg DA, Bennett JK, et al. Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence. J Urol 2003;169(1):199-202.

Klausner AP, Steers WD. The neurogenic bladder: an update with management strategies for primary care physicians. Med Clin North Am 2011;95(1):111-20.

Taweel WA, Seyam R. Neurogenic bladder in spinal cord injury patients. Research and Reports in Urology 2015;7:85-99.

Tins B, Teo HG, et al. Follow-up imaging of the urinary tract in spinal injury patients: is a KUB necessary with every ultrasound? Spinal Cord 2005;43(4):219-222.

Schafer W, Abrams P, Liao L, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21(3):261-74.

Winters JC, Dmochowski RR, Goldman HB, et al. Urodynamic studies in adults: AUA/SUFU guideline. J Urol 2012;188(Suppl 6):2464-72.

Stohrer M, Blok B, Castro-Diaz D, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 2009;56(1):81-8.

Homma Y, editor. Urodynamics. 2nd International Consultation on Incontinence; 2002 July 1-3, 2001. Paris: Plymbridge Distributors, Ltd. 2002.

Nosseir M, Hinkel A, Pannek J. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn 2007;26(2):228-

Dahl DM, McDougal WS. Use of intestinal segments in urinary diversion. In: Wein AJ, Kavoussi LR, Novick AC, et, al, editors. Campbell-Walsh urology, vol. 3, 10th edition. Philadelphia: Elsevier; 2012. p. 2411-49.

Hamid R, Greenwell TJ, Nethercliffe JM, et al. Routine surveillance cystoscopy for patients with augmentation and substitution cystoplasty for benign urologic conditions: is it necessary? BJU Int 2009;104(3):392-5.

Hess MJ, Zhan EH, Foo DK. Bladder cancer in patients with spinal cord injury. J Spinal Cord Med 2003;26(4):335-8.

Park YI, Linsenmeyer TI. A method to minimize indwelling catheter calcification and bladder stones in individuals with spinal cord injury. J Spinal Cord Med 2001;24(2):105-8.

Chen Y, DeVivo MJ, Stover SL, Lloyd LK. Recurrent kidney stone: a 25-year follow-up study in persons with spinal cord injury. Urology 2002;60(2);228-32.

Hackler RH, Dalton JJ Jr, Bunts RC. Changing concepts in the preservation of renal function in the paraplegic. J Urol 1965;94:107-11.

Lisenmeyer et al. Silent autonomic dysreflexia during voiding in men with spinal cord injury. J Urol. 1996;155:19-22.

Hou S, Rabchevsky AG. Autonomic consequences of spinal cord injury. Compr Physiol 2014;4(4):1419-53.

Altaweel W, Corcos J. Pathophysiology of autonomic dysreflexia. In: Corcos J, Schick E, editors. Textbook of the Neurogenic Bladder. London, UK: Martin Dunitz, Taylor and Francis Group; 2004.

Gokalp A, Yildirim I, Aydur E, et al. How to manage acute urethral false passage due to intermittent catheterization in spinal cord injured patients who refused insertion of an indwelling catheter. J Urol 2003;169(1)203-6.



  • There are currently no refbacks.
Copyright 2016. All rights reserved.